Is going public in your future?

Download our infographic to assess your readiness

Life sciences

Don’t underestimate the level of effort to go public

Operating in the life sciences industry can bring a variety of challenges, not the least of which is raising capital. Going public is a transformative event, and also a complex, distracting and time-consuming transaction which presents high execution risk. Research shows that the most successful public companies started acting like they were public long before the transaction.

Featured insights

The process is daunting. Preparation is paramount.

Going public requires sound business reporting adherence to strict SEC compliance rules and the involvement of numerous trusted advisors to successfully survive the process. At RSM, we work with you to understand the company's financial statements from a public company lens, evaluate your current internal resources and skills, and help construct a realistic capital markets readiness road map for financial reporting and SEC compliance.

Contact our life sciences IPO-readiness team

Complete this form and an RSM representative will be in touch shortly.